Clinical Trial Update: Drug Use Survey (DUS) of Triple Therapy (Methycobal (MBL)+ Myonal (MYO)+ Non-steroidal Anti-inflammatory Drags (NSAID)) on the Symptom Relief of Lumbar DDD in China

View source ↗

Summary

A completed clinical trial update from Eisai China evaluates symptom relief in Lumbar Disc Degenerative Disease using triple therapy with Methycobal, Myonal, an…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Lumbar Disc Degenerative Disease

Drugs mentioned

• Methycobal (methylcobalamin)
• Myonal
• NSAID (Non-steroidal anti-inflammatory drug)

Snippet

Sponsor: Eisai China Inc. | Conditions: Lumbar Disc Degenerative Disease | Status: COMPLETED | Results posted: 2011-11-28